Emerging drugs for the treatment of ulcerative colitis

Pathogenesis of and Unifying Hypothesis for Idiopathic Pouchitis

(2009) J Calvin Coffey et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Effect of a Probiotic Preparation (VSL#3) on Induction and Maintenance of Remission in Children With Ulcerative Colitis

(2009) Erasmo Miele et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Probiotic E. coli treatment mediates antimicrobial human β-defensin synthesis and fecal excretion in humans

(2009) M Möndel et al.   Mucosal Immunology

Oral, colonic-release low-molecular-weight heparin: an initial open study of Parnaparin-MMX for the treatment of mild-to-moderate left-sided ulcerative colitis

(2008) L. PASTORELLI et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Long-term outcome of adalimumab therapy for ulcerative colitis with intolerance or lost response to infliximab: a single-centre experience

(2008) A. OUSSALAH et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Erythrocyte-Mediated Delivery of Dexamethasone in Patients With Mild-to-Moderate Ulcerative Colitis, Refractory to Mesalamine: A Randomized, Controlled Study

(2008) Fabrizio Bossa et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Golimumab, a human antibody to tumour necrosis factor   given by monthly subcutaneous injections, in active rheumatoid arthritis despite methotrexate therapy: the GO-FORWARD Study

(2008) E C Keystone et al.   ANNALS OF THE RHEUMATIC DISEASES

Visilizumab induces apoptosis of mucosal T lymphocytes in ulcerative colitis through activation of caspase 3 and 8 dependent pathways

(2008) Qi T. Yu et al.   CLINICAL IMMUNOLOGY

The use of thiopurines for the treatment of inflammatory bowel diseases in clinical practice

(2008) S. Saibeni et al.   DIGESTIVE AND LIVER DISEASE

Efficacy of Intracolonic Administration of Low-Molecular-Weight Heparin CB-01-05, Compared to Other Low-Molecular-Weight Heparins and Unfractionated Heparin, in Experimentally Induced Colitis in Rat

(2008) Giuseppe Celasco et al.   DIGESTIVE DISEASES AND SCIENCES

A Randomized, Double-Blind, Sham-Controlled Study of Granulocyte/Monocyte Apheresis for Active Ulcerative Colitis

(2008) Bruce E. Sands et al.   GASTROENTEROLOGY

Rosiglitazone for Active Ulcerative Colitis: A Randomized Placebo-Controlled Trial

(2008) James D. Lewis et al.   GASTROENTEROLOGY

Randomised trial of once- or twice-daily MMX mesalazine for maintenance of remission in ulcerative colitis

(2008) M A Kamm et al.   GUT

Mechanisms of probiotic action: Implications for therapeutic applications in inflammatory bowel diseases

(2008) Charles Vanderpool et al.   INFLAMMATORY BOWEL DISEASES

Probiotic preparation VSL#3 induces remission in children with mild to moderate acute ulcerative colitis: A pilot study

(2008) Hien Q. Huynh et al.   INFLAMMATORY BOWEL DISEASES

Molecular analysis of the intestinal microflora in IBD

(2008) G W Tannock   Mucosal Immunology

TGF-β1 and Smad7 in the regulation of IBD

(2008) G Monteleone et al.   Mucosal Immunology

A clinical trial of combined use of rosiglitazone and 5-aminosalicylate for ulcerative colitis

(2008) Hong-Liang Liang et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Risk for colorectal cancer in ulcerative colitis: Changes, causes and management strategies

(2008) Peter Laszlo Lakatos et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Role of the intestinal barrier in inflammatory bowel disease

(2008) Mike G Laukoetter et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Cell-based drug delivery

(2007) F. Pierigè et al.   ADVANCED DRUG DELIVERY REVIEWS

TNFα blockade in human diseases: An overview of efficacy and safety

(2007) Jan Lin et al.   CLINICAL IMMUNOLOGY

Quality of life of patients with ulcerative colitis: Past, present, and future

(2007) Jan E. Irvine   INFLAMMATORY BOWEL DISEASES